David‐Alexandre Trégouët

33.2k total citations
189 papers, 6.8k citations indexed

About

David‐Alexandre Trégouët is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, David‐Alexandre Trégouët has authored 189 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Hematology, 58 papers in Molecular Biology and 49 papers in Genetics. Recurrent topics in David‐Alexandre Trégouët's work include Blood Coagulation and Thrombosis Mechanisms (53 papers), Genetic Associations and Epidemiology (39 papers) and Venous Thromboembolism Diagnosis and Management (35 papers). David‐Alexandre Trégouët is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (53 papers), Genetic Associations and Epidemiology (39 papers) and Venous Thromboembolism Diagnosis and Management (35 papers). David‐Alexandre Trégouët collaborates with scholars based in France, United States and United Kingdom. David‐Alexandre Trégouët's co-authors include Pierre‐Emmanuel Morange, Laurence Tiret, Marie‐Christine Alessi, I. Juhan‐Vague, Marine Germain, Noémie Saut, Florent Soubrier, François Cambien, Marc Humbert and Barbara Girerd and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

David‐Alexandre Trégouët

181 papers receiving 6.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David‐Alexandre Trégouët France	45	1.9k	1.3k	1.2k	1.2k	1.0k	189	6.8k
Paul F. Bray United States	53	2.0k 1.0×	3.3k 2.5×	2.9k 2.4×	809 0.7×	1.1k 1.0×	175	8.8k
Susan S. Smyth United States	46	2.7k 1.4×	1.1k 0.8×	1.7k 1.4×	513 0.4×	269 0.3×	149	6.5k
Alison H. Goodall United Kingdom	47	1.2k 0.6×	2.0k 1.6×	1.6k 1.3×	851 0.7×	401 0.4×	153	6.1k
Takao Koike Japan	56	1.8k 0.9×	3.3k 2.6×	467 0.4×	787 0.7×	1.3k 1.3×	332	12.4k
Fiorella Guadagni Italy	42	1.6k 0.9×	336 0.3×	523 0.4×	759 0.7×	394 0.4×	210	5.7k
Solbritt Rantapää‐Dahlqvist Sweden	61	1.6k 0.8×	1.5k 1.2×	1.2k 1.0×	958 0.8×	807 0.8×	248	12.6k
Kenneth A. Ault United States	47	1.1k 0.6×	2.0k 1.6×	1.1k 0.9×	682 0.6×	426 0.4×	102	7.3k
Michael Lishner Israel	42	1.2k 0.6×	770 0.6×	808 0.7×	616 0.5×	333 0.3×	238	6.0k
Andrew L. Frelinger United States	50	1.3k 0.7×	3.2k 2.5×	4.0k 3.3×	945 0.8×	355 0.3×	170	9.0k
Cristiano Alessandri Italy	47	1.4k 0.7×	1.1k 0.8×	468 0.4×	450 0.4×	514 0.5×	305	6.8k

Countries citing papers authored by David‐Alexandre Trégouët

Since Specialization

Citations

This map shows the geographic impact of David‐Alexandre Trégouët's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David‐Alexandre Trégouët with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David‐Alexandre Trégouët more than expected).

Fields of papers citing papers by David‐Alexandre Trégouët

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David‐Alexandre Trégouët. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David‐Alexandre Trégouët. The network helps show where David‐Alexandre Trégouët may publish in the future.

Co-authorship network of co-authors of David‐Alexandre Trégouët

This figure shows the co-authorship network connecting the top 25 collaborators of David‐Alexandre Trégouët. A scholar is included among the top collaborators of David‐Alexandre Trégouët based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David‐Alexandre Trégouët. David‐Alexandre Trégouët is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Trégouët, David‐Alexandre, Sébastien Campagne, Vincent Michaud, et al.. (2025). From paleness to albinism: Contribution of OCA2 exon 10 skipping to hypopigmentation. PLoS Genetics. 21(9). e1011801–e1011801.

2.

Rodger, Marc, Michael J. Kovacs, Grégoire Le Gal, et al.. (2025). Sex-specific DNA methylation marks associated with sex-biased risk of recurrence in unprovoked venous thromboembolism. Journal of Thrombosis and Haemostasis. 23(4). 1379–1392.

3.

Soumaré, Aïcha, Christophe Tzourio, Stéphanie Debette, et al.. (2024). Evaluation of clonal hematopoiesis and mosaic loss of Y chromosome in cardiovascular risk: An analysis in prospective studies. eLife. 13. 1 indexed citations

4.

Sayed, Zeina R. Al, Rémi Le Borgne, Christine Viaris de Lesegno, et al.. (2024). CAVIN1-Mediated hERG Dynamics: A Novel Mechanism Underlying the Interindividual Variability in Drug-Induced Long QT. Circulation. 150(7). 563–576. 2 indexed citations

5.

Suchon, Pierre, Omar Soukarieh, C. Bernard, et al.. (2024). Assessment of a next generation sequencing gene panel strategy in 133 patients with negative thrombophilia screening. Journal of Thrombosis and Haemostasis. 23(3). 997–1008. 1 indexed citations

6.

Soumaré, Aïcha, Christophe Tzourio, Stéphanie Debette, et al.. (2024). Evaluation of clonal hematopoiesis and mosaic loss of Y chromosome in cardiovascular risk: An analysis in prospective studies. eLife. 13. 1 indexed citations

7.

Trégouët, David‐Alexandre & Pierre‐Emmanuel Morange. (2024). Next-generation sequencing strategies in venous thromboembolism: in whom and for what purpose?. Journal of Thrombosis and Haemostasis. 22(7). 1826–1834. 2 indexed citations

8.

Haycock, Philip, Hermann Brenner, Jane C. Figueiredo, et al.. (2023). Causal relationships between risk of venous thromboembolism and 18 cancers: a bidirectional Mendelian randomization analysis. International Journal of Epidemiology. 53(1). 1 indexed citations

9.

Morena‐Barrio, María Eugenia de la, Pierre Suchon, E. Jacobsen, et al.. (2022). Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays. Blood. 140(2). 140–151. 17 indexed citations

10.

Mégy, Karyn, Kate Downes, Marie‐Christine Morel‐Kopp, et al.. (2021). GoldVariants, a resource for sharing rare genetic variants detected in bleeding, thrombotic, and platelet disorders: Communication from the ISTH SSC Subcommittee on Genomics in Thrombosis and Hemostasis. Journal of Thrombosis and Haemostasis. 19(10). 2612–2617. 34 indexed citations

11.

Ellervik, Christina, Samia Mora, Aleksander Kuś, et al.. (2021). Effects of Thyroid Function on Hemostasis, Coagulation, and Fibrinolysis: A Mendelian Randomization Study. Thyroid. 31(9). 1305–1315. 18 indexed citations

12.

Sandholm, Niina, David‐Alexandre Trégouët, Amy Jayne McKnight, et al.. (2020). Genome-wide association study on coronary artery disease in type 1 diabetes suggests beta-defensin 127 as a risk locus. Cardiovascular Research. 117(2). 600–612. 15 indexed citations

13.

Desch, Karl C., Ayse Bilge Ozel, Matthew Halvorsen, et al.. (2020). Whole-exome sequencing identifies rare variants in STAB2 associated with venous thromboembolic disease. Blood. 136(5). 533–541. 31 indexed citations

14.

Thibord, Florian, Claire Perret, Maguelonne Roux, et al.. (2019). OPTIMIR, a novel algorithm for integrating available genome-wide genotype data into miRNA sequence alignment analysis. RNA. 25(6). 657–668. 6 indexed citations

15.

Trégouët, David‐Alexandre & Pierre‐Emmanuel Morange. (2017). What is currently known about the genetics of venous thromboembolism at the dawn of next generation sequencing technologies. British Journal of Haematology. 180(3). 335–345. 24 indexed citations

16.

Desch, Karl C., Ayse Bilge Ozel, Matthew Halvorsen, et al.. (2017). Exome Sequencing Studies Identify Mutations in STAB2 As a Genetic Risk for Venous Thromboembolic Disease. Blood. 130. 457–457. 4 indexed citations

17.

Marchand, Alexandre, Fabrice Atassi, Nathalie Mougenot, et al.. (2016). miR-322 regulates insulin signaling pathway and protects against metabolic syndrome-induced cardiac dysfunction in mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862(4). 611–621. 34 indexed citations

18.

Bruzelius, Maria, María Jesús Iglesias, Laura Sánchez‐Rivera, et al.. (2016). PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics study. Blood. 128(23). e59–e66. 40 indexed citations

19.

Girerd, Barbara, David Montani, Florence Coulet, et al.. (2010). Clinical Outcomes of Pulmonary Arterial Hypertension in Patients Carrying an ACVRL1 ( ALK1 ) Mutation. American Journal of Respiratory and Critical Care Medicine. 181(8). 851–861. 215 indexed citations

20.

Vionnet, Nathalie, Michel Marre, Per‐Henrik Groop, et al.. (2006). The canosinase gene (CNDP1) is not a protection factor of diabetic nephropathy in type 1 diabetics. Diabetes & Metabolism. 32. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact